Streetbeat News

Earnings

STNG

Scorpio Tankers (STNG) reported Q3 2023 earnings per share (EPS) of $1.91, surpassing the estimate of $1.55. The company's revenue of $291.176M also beat the estimate of $281.75M.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:41 pm

AVTX

Avalo Therapeutics reported Q3 losses of $(0.11) per share, a 132.35% decrease YoY. The company's sales also decreased by 98.42% to $236.00K from $14.95M in the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:40 pm

GLUE

Monte Rosa Therapeutics (NASDAQ:GLUE) reported Q3 losses of $(0.70) per share, beating the analyst consensus estimate of $(0.72) by 2.78%. This is a 20.69% decrease over losses of $(0.58) per share from the same period last year. The company's cash, cash equivalents, restricted cash, and marketable securities of $183M are sufficient to fund planned operations and capital expenditures into 1H of 2026.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:38 pm

NTLA

Intellia Therapeutics has reported a cash balance of $992.5 million at the end of Q3.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:37 pm

REAX

Real Brokerage (NASDAQ:REAX) reported Q3 2023 earnings per share (EPS) of $(0.02), beating the analyst consensus estimate of $(0.03) by 33.33%. The company also reported quarterly sales of $214.64 million, surpassing the analyst consensus estimate of $183.58 million by 16.92%. This represents a 92.27% increase over sales from the same period last year.

Portfolio Pulse from totan@benzinga.com

November 09, 2023 | 12:37 pm

HCA

HCA Healthcare has projected an adjusted EBITDA growth of 4%-6% and EPS growth of 8%-12% over the next five years.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:36 pm

VRCA

Verrica Pharmaceuticals reported Q3 adjusted losses of $(0.32) per share, beating the analyst consensus estimate of $(0.36) by 11.11%. The company also reported quarterly sales of $2.92 million, surpassing the analyst consensus estimate of $510.00 thousand by 471.96%. However, this represents a 557.14% decrease in earnings and a 64.94% decrease in sales compared to the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:36 pm

ABBV

OGN

PINC

Three health care stocks with over 4% dividend yields have been highlighted by Wall Street's most accurate analysts. Organon & Co. (OGN) has a dividend yield of 9.13% but posted weaker-than-expected Q3 results. AbbVie Inc. (ABBV) has a dividend yield of 4.37% and reported better-than-expected Q3 earnings, raising its profit outlook. Premier, Inc. (PINC) has a dividend yield of 4.24% and posted stronger-than-expected Q1 earnings.

Portfolio Pulse from Lisa Levin

November 09, 2023 | 12:36 pm

NTLA

Intellia Therapeutics reported Q3 losses of $(1.38) per share, beating the analyst consensus estimate of $(1.50) by 8 percent. However, the company's quarterly sales of $11.99 million missed the analyst consensus estimate of $12.45 million by 3.68 percent.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:36 pm

SPH

Suburban Propane Partners (NYSE:SPH) reported Q4 losses of $(0.33) per share, beating the analyst consensus estimate of $(0.45) by 26.67%. However, the company's quarterly sales of $226.59 million missed the analyst consensus estimate of $233.00 million by 2.75%. This represents a 4.65% decrease over sales from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

November 09, 2023 | 12:35 pm